Corporate Presentation
Importance of nitric oxide, our pipeline, and our plans for market disruption.
-
Compassionate Nitric Oxide Adjuvant Treatment of Persistent Mycobacterium Infection in Cystic Fibrosis Patients. Pediatr Infect Dis J. 2018; 37(4):336-338.
Yaacoby-Bianu, K., et al. (2018) • April 2018 -
Nitric oxide inhalations in bronchiolitis: A pilot, randomized, double-blinded, controlled trial. Pediatr Pulmonol 53(1): 95-102.
Tal, A., et al. (2018) • January 2018 -
Prospective Open-Label Phase 2a Trial of Adjuvant Nitric Oxide Cystic Fibrosis Therapy
Blau H et al. (2014) • February 10, 2014 -
A phase I clinical study of inhaled nitric oxide in healthy adults. Journal of Cystic Fibrosis, 11:324-331
Miller CC. et al., (2012) • April 20, 2012 -
Innate protection of Mycobacterium smegmatis against the antimicrobial activity of nitric oxide is provided by mycothiol. Antimicrob Agents Chemother. 2007 Sep;51(9):3364-6. Epub 2007
Miller CC, et al. (2007) • July 2017 -
Potential application of gaseous nitric oxide as a topical antimicrobial agent. Nitric Oxide 14: 21-29
Ghaffari, A., et al. (2006) • February 2006 -
The antimicrobial effect of nitric oxide on the bacteria that cause nosocomial pneumonia in mechanically ventilated patients in the intensive care unit. Respir Care. 2005 Nov;50(11):1451-6.
McMullin BB, et al. (2005) • November 2005 -
A direct nitric oxide gas delivery system for bacterial and mammalian cell cultures. Nitric Oxide 12: 129-140.
Ghaffari, A. et al. (2005) • May 2005 -
Treatment of chronic nonhealing leg ulceration with gaseous nitric oxide: a case study. J Cutan Med Surg.
Miller CC, et al. (2004) • July 1, 2004